Article
A Homozygous RET K666N Genotype With an MEN2A Phenotype.
The Journal of clinical endocrinology and metabolism - 1 Apr 2018
Jaber Tania, Hyde Samuel M, Cote Gilbert J, Grubbs Elizabeth G, Giles Wesley H, Stevens Cathy A, Dadu Ramona
Abstract excerpt
Context: Germline RET K666N mutation has been described as a pathogenic mutation with low disease penetrance for medullary thyroid cancer (MTC) without other features of multiple endocrine neoplasia type 2A. We describe a patient with homozygous RET K666N mutation with MTC and bilateral pheochromocytoma (PHEO). Case Description: A 59-year-old woman received a diagnosis of MTC after biopsy of two thyroid nodules....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
